Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for CSTL

Stock Name	Castle Biosciences Inc
Ticker	CSTL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US14843C1053

Show aggregate CSTL holdings

News associated with CSTL

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of “Moderate Buy” by Brokerages: Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price objective among brokerages […] - 2025-09-04 02:46:48
Mackenzie Financial Corp Has $550,000 Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL): Mackenzie Financial Corp boosted its holdings in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 30.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,460 shares of the company’s stock after buying an additional 6,440 shares during the period. Mackenzie Financial Corp […] - 2025-08-08 05:02:56
Castle Biosciences (NASDAQ:CSTL) Shares Gap Up Following Earnings Beat: Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) shares gapped up prior to trading on Tuesday following a better than expected earnings announcement. The stock had previously closed at $15.32, but opened at $19.85. Castle Biosciences shares last traded at $21.06, with a volume of 249,752 shares traded. The company reported $0.15 EPS for the […] - 2025-08-07 02:13:00
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Shares in Castle Biosciences, Inc. (NASDAQ:CSTL): Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 1st quarter, HoldingsChannel.com reports. The fund purchased 11,753 shares of the company’s stock, valued at approximately $235,000. A number of other institutional investors have also added to or reduced their stakes in CSTL. Allianz Asset Management […] - 2025-08-05 04:38:48
Envestnet Asset Management Inc. Has $1.40 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL): Envestnet Asset Management Inc. decreased its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 4.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 69,771 shares of the company’s stock after selling 3,573 shares during the quarter. Envestnet Asset Management Inc. owned […] - 2025-08-01 05:01:11
GSA Capital Partners LLP Sells 3,658 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): GSA Capital Partners LLP decreased its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 5.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 67,143 shares of the company’s stock after selling 3,658 shares during the period. GSA Capital Partners LLP owned about 0.23% of […] - 2025-07-31 05:32:57
Stephens Inc. AR Sells 800 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): Stephens Inc. AR cut its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 5.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 13,639 shares of the company’s stock after selling 800 shares during the period. Stephens Inc. AR’s holdings in Castle Biosciences were worth $273,000 as of its most recent filing […] - 2025-07-21 05:10:45
Brokerages Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $37.00: Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given an average rating of “Buy” by the eight brokerages that are currently covering the company, MarketBeat.com reports. Eight analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock in the […] - 2025-06-24 02:16:45
Two Sigma Advisers LP Takes Position in Castle Biosciences, Inc. (NASDAQ:CSTL): Two Sigma Advisers LP acquired a new stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund acquired 11,500 shares of the company’s stock, valued at approximately $306,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Covestor Ltd acquired […] - 2025-06-06 05:12:48
Squarepoint Ops LLC Trims Position in Castle Biosciences, Inc. (NASDAQ:CSTL): Squarepoint Ops LLC trimmed its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 51.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,317 shares of the company’s stock after selling 18,142 shares during the period. Squarepoint Ops LLC’s holdings in Castle Biosciences were […] - 2025-06-05 05:04:48
Public Employees Retirement System of Ohio Lowers Stake in Castle Biosciences, Inc. (NASDAQ:CSTL): Public Employees Retirement System of Ohio lowered its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 16.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 74,132 shares of the company’s stock after selling 14,776 shares […] - 2025-06-02 05:34:54
Man Group plc Buys Shares of 13,302 Castle Biosciences, Inc. (NASDAQ:CSTL): Man Group plc bought a new stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 13,302 shares of the company’s stock, valued at approximately $354,000. Several other hedge funds have also recently made changes […] - 2025-05-27 05:34:50
Nuveen Asset Management LLC Has $12.41 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL): Nuveen Asset Management LLC lowered its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 14.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 465,526 shares of the company’s stock after selling 77,067 shares during the period. Nuveen Asset Management LLC’s holdings in […] - 2025-05-27 04:44:54
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Rating of “Buy” from Analysts: Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have received an average recommendation of “Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. Eight equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have updated their coverage on […] - 2025-05-27 02:32:56
D. E. Shaw & Co. Inc. Makes New $2.41 Million Investment in Castle Biosciences, Inc. (NASDAQ:CSTL): D. E. Shaw & Co. Inc. acquired a new position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 90,563 shares of the company’s stock, valued at approximately $2,414,000. Other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & […] - 2025-05-21 05:44:54
Ameriprise Financial Inc. Sells 33,193 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): Ameriprise Financial Inc. trimmed its holdings in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 316,036 shares of the company’s stock after selling 33,193 shares during the quarter. Ameriprise Financial Inc.’s […] - 2025-05-21 04:28:51
Castle Biosciences, Inc. (NASDAQ:CSTL) Stake Cut by Jane Street Group LLC: Jane Street Group LLC cut its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 59.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 59,383 shares of the company’s stock after selling 86,001 shares during the quarter. Jane Street Group […] - 2025-05-19 04:56:50
Schonfeld Strategic Advisors LLC Sells 40,700 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): Schonfeld Strategic Advisors LLC cut its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 72.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 15,300 shares of the company’s stock after selling 40,700 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in Castle Biosciences were worth $408,000 as of […] - 2025-05-12 05:42:51
Wells Fargo & Company MN Buys 3,460 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): Wells Fargo & Company MN lifted its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 29.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,375 shares of the company’s stock after acquiring an additional 3,460 shares during the period. Wells […] - 2025-05-05 04:23:03
CANADA LIFE ASSURANCE Co Sells 2,506 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): CANADA LIFE ASSURANCE Co trimmed its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 19.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,713 shares of the company’s stock after selling 2,506 shares during the quarter. CANADA LIFE ASSURANCE Co’s holdings […] - 2025-05-01 05:40:55
LPL Financial LLC Sells 3,421 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): LPL Financial LLC decreased its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 12.9% in the 4th quarter, Holdings Channel reports. The fund owned 23,043 shares of the company’s stock after selling 3,421 shares during the quarter. LPL Financial LLC’s holdings in Castle Biosciences were worth $614,000 as of its most […] - 2025-04-24 04:16:59
ExodusPoint Capital Management LP Sells 32,779 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): ExodusPoint Capital Management LP cut its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 74.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 11,484 shares of the company’s stock after selling 32,779 shares during the period. ExodusPoint Capital Management LP’s holdings in Castle Biosciences were […] - 2025-04-14 05:58:59
Corebridge Financial Inc. Sells 972 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): Corebridge Financial Inc. lessened its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 7.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,860 shares of the company’s stock after selling 972 shares during the quarter. Corebridge Financial Inc.’s holdings in Castle Biosciences […] - 2025-04-11 04:54:48
Brokerages Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $38.75: Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given a consensus rating of “Buy” by the eight brokerages that are currently covering the company, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued a report on the stock […] - 2025-04-10 03:07:07
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Sei Investments Co.: Sei Investments Co. lifted its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 9.6% during the 4th quarter, HoldingsChannel reports. The fund owned 41,491 shares of the company’s stock after acquiring an additional 3,617 shares during the period. Sei Investments Co.’s holdings in Castle Biosciences were worth $1,106,000 at the end […] - 2025-04-08 04:31:12
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Intech Investment Management LLC: Intech Investment Management LLC increased its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 39.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,578 shares of the company’s stock after purchasing an additional 3,294 shares during the quarter. Intech Investment […] - 2025-03-26 06:23:12
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Rating of “Buy” by Brokerages: Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have earned an average rating of “Buy” from the seven research firms that are covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued ratings on the stock in […] - 2025-03-13 04:20:58
Rhumbline Advisers Reduces Stake in Castle Biosciences, Inc. (NASDAQ:CSTL): Rhumbline Advisers reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,892 shares of the company’s stock after selling 1,009 shares during the quarter. Rhumbline Advisers’ holdings in […] - 2025-03-06 07:53:36
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives $40.29 Consensus Target Price from Brokerages: Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been given a consensus rating of “Buy” by the seven research firms that are presently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have covered the stock […] - 2025-02-21 05:11:00
R Squared Ltd Acquires Shares of 1,590 Castle Biosciences, Inc. (NASDAQ:CSTL): R Squared Ltd acquired a new stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,590 shares of the company’s stock, valued at approximately $42,000. Other institutional investors and […] - 2025-02-03 06:49:05

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) CSTL holdings

Date	Number of CSTL Shares Held	Base Market Value of CSTL Shares	Local Market Value of CSTL Shares	Change in CSTL Shares Held	Change in CSTL Base Value	Current Price per CSTL Share Held	Previous Price per CSTL Share Held
2025-11-11 (Tuesday)	18,690	USD 653,589	USD 653,589	0	USD 4,298	USD 34.97	USD 34.74
2025-11-10 (Monday)	18,690	USD 649,291	USD 649,291	48	USD 33,359	USD 34.74	USD 33.04
2025-11-07 (Friday)	18,642	USD 615,932	USD 615,932	0	USD -9,507	USD 33.04	USD 33.55
2025-11-06 (Thursday)	18,642	USD 625,439	USD 625,439	48	USD 1,238	USD 33.55	USD 33.57
2025-11-05 (Wednesday)	18,594	USD 624,201	USD 624,201	48	USD 37,591	USD 33.57	USD 31.63
2025-11-04 (Tuesday)	18,546	USD 586,610	USD 586,610	0	USD 104,599	USD 31.63	USD 25.99
2025-11-03 (Monday)	18,546	USD 482,011	USD 482,011	0	USD 9,088	USD 25.99	USD 25.5
2025-10-31 (Friday)	18,546	USD 472,923	USD 472,923	0	USD 23,924	USD 25.5	USD 24.21
2025-10-30 (Thursday)	18,546	USD 448,999	USD 448,999	240	USD 14,415	USD 24.21	USD 23.74
2025-10-29 (Wednesday)	18,306	USD 434,584	USD 434,584	96	USD -5,188	USD 23.74	USD 24.15
2025-10-28 (Tuesday)	18,210	USD 439,772	USD 439,772	0	USD 3,460	USD 24.15	USD 23.96
2025-10-27 (Monday)	18,210	USD 436,312	USD 436,312	0	USD -10,015	USD 23.96	USD 24.51

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CSTL by Blackrock for IE00BDZVHG35

Show aggregate share trades of CSTL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 48 34.830 32.510 32.742 USD 1,572 23.27
2025-11-06 BUY 48 33.969 33.060 33.151 USD 1,591 23.16
2025-11-05 BUY 48 34.360 31.555 31.836 USD 1,528 23.11
2025-10-30 BUY 240 24.430 23.730 23.800 USD 5,712 23.02
2025-10-29 BUY 96 23.740 24.640 24.550 USD 2,357 23.02
2025-10-22 SELL -192 23.740 23.850 23.839 USD -4,577 22.99 Loss of -163 on sale
2025-10-20 BUY 96 23.010 23.210 23.190 USD 2,226 22.99
2025-10-17 BUY 240 22.140 22.740 22.680 USD 5,443 22.99
2025-10-15 BUY 384 22.510 22.820 22.789 USD 8,751 22.99
2025-10-03 BUY 336 22.720 23.377 23.311 USD 7,833 23.00
2025-10-02 BUY 48 22.230 23.170 23.076 USD 1,108 23.00
2025-09-30 BUY 96 22.770 22.810 22.806 USD 2,189 23.01
2025-09-26 BUY 96 22.710 23.140 23.097 USD 2,217 23.01
2025-09-25 BUY 96 22.740 23.180 23.136 USD 2,221 23.01
2025-09-18 BUY 49 23.460 23.490 23.487 USD 1,151 23.01
2025-09-17 BUY 147 21.820 22.570 22.495 USD 3,307 23.02
2025-09-11 SELL -49 22.750 23.570 23.488 USD -1,151 23.03 Loss of -23 on sale
2025-09-10 BUY 98 22.940 24.650 24.479 USD 2,399 23.03
2025-07-17 SELL -96 17.390 18.915 18.763 USD -1,801 23.14 Profit of 420 on sale
2025-07-11 SELL -384 19.660 19.900 19.876 USD -7,632 23.24 Profit of 1,292 on sale
2025-07-02 BUY 2,640 20.010 20.565 20.510 USD 54,145 23.33
2025-06-25 BUY 96 19.470 19.585 19.573 USD 1,879 23.42
2025-06-11 BUY 98 18.440 18.670 18.647 USD 1,827 23.77
2025-06-10 BUY 98 18.040 18.460 18.418 USD 1,805 23.81
2025-06-04 SELL -49 17.020 17.055 17.052 USD -836 24.01 Profit of 341 on sale
2025-04-23 BUY 49 21.270 22.815 22.661 USD 1,110 26.00
2025-04-10 SELL -384 19.300 19.800 19.750 USD -7,584 26.52 Profit of 2,600 on sale
2025-04-08 SELL -48 18.600 20.100 19.950 USD -958 26.69 Profit of 323 on sale
2025-04-07 SELL -48 19.090 19.965 19.878 USD -954 26.77 Profit of 331 on sale
2025-04-04 SELL -245 18.570 18.990 18.948 USD -4,642 26.87 Profit of 1,941 on sale
2025-04-01 BUY 200 19.780 20.220 20.176 USD 4,035 27.04
2025-03-31 SELL -147 20.020 20.300 20.272 USD -2,980 27.12 Profit of 1,007 on sale
2025-03-21 BUY 1,251 20.520 21.010 20.961 USD 26,222 27.65
2025-03-14 SELL -736 19.290 19.550 19.524 USD -14,370 28.19 Profit of 6,375 on sale
2025-03-07 SELL -90 20.210 20.915 20.845 USD -1,876 28.85 Profit of 720 on sale
2025-03-04 SELL -45 22.230 22.580 22.545 USD -1,015 29.21 Profit of 300 on sale
2025-02-25 BUY 90 25.090 25.360 25.333 USD 2,280 29.67
2025-02-19 SELL -45 27.190 27.565 27.528 USD -1,239 29.93 Profit of 108 on sale
2025-02-13 BUY 132 27.610 28.480 28.393 USD 3,748 30.14
2025-02-12 BUY 44 27.850 28.270 28.228 USD 1,242 30.19
2025-02-11 BUY 176 28.120 28.220 28.210 USD 4,965 30.23
2024-12-30 SELL -1,533 26.660 26.790 26.777 USD -41,049 31.45 Profit of 7,156 on sale
2024-11-18 SELL -720 27.900 28.820 28.728 USD -20,684 32.79 Profit of 2,922 on sale
2024-11-08 SELL -48 33.290 33.870 33.812 USD -1,623 32.75 Loss of -51 on sale
2024-10-21 SELL -49 31.870 33.300 33.157 USD -1,625 0.00 Loss of -1,625 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	48	34.830	32.510	32.742	USD 1,572	23.27
2025-11-06	BUY	48	33.969	33.060	33.151	USD 1,591	23.16
2025-11-05	BUY	48	34.360	31.555	31.836	USD 1,528	23.11
2025-10-30	BUY	240	24.430	23.730	23.800	USD 5,712	23.02
2025-10-29	BUY	96	23.740	24.640	24.550	USD 2,357	23.02
2025-10-22	SELL	-192	23.740	23.850	23.839	USD -4,577	22.99 Loss of -163 on sale
2025-10-20	BUY	96	23.010	23.210	23.190	USD 2,226	22.99
2025-10-17	BUY	240	22.140	22.740	22.680	USD 5,443	22.99
2025-10-15	BUY	384	22.510	22.820	22.789	USD 8,751	22.99
2025-10-03	BUY	336	22.720	23.377	23.311	USD 7,833	23.00
2025-10-02	BUY	48	22.230	23.170	23.076	USD 1,108	23.00
2025-09-30	BUY	96	22.770	22.810	22.806	USD 2,189	23.01
2025-09-26	BUY	96	22.710	23.140	23.097	USD 2,217	23.01
2025-09-25	BUY	96	22.740	23.180	23.136	USD 2,221	23.01
2025-09-18	BUY	49	23.460	23.490	23.487	USD 1,151	23.01
2025-09-17	BUY	147	21.820	22.570	22.495	USD 3,307	23.02
2025-09-11	SELL	-49	22.750	23.570	23.488	USD -1,151	23.03 Loss of -23 on sale
2025-09-10	BUY	98	22.940	24.650	24.479	USD 2,399	23.03
2025-07-17	SELL	-96	17.390	18.915	18.763	USD -1,801	23.14 Profit of 420 on sale
2025-07-11	SELL	-384	19.660	19.900	19.876	USD -7,632	23.24 Profit of 1,292 on sale
2025-07-02	BUY	2,640	20.010	20.565	20.510	USD 54,145	23.33
2025-06-25	BUY	96	19.470	19.585	19.573	USD 1,879	23.42
2025-06-11	BUY	98	18.440	18.670	18.647	USD 1,827	23.77
2025-06-10	BUY	98	18.040	18.460	18.418	USD 1,805	23.81
2025-06-04	SELL	-49	17.020	17.055	17.052	USD -836	24.01 Profit of 341 on sale
2025-04-23	BUY	49	21.270	22.815	22.661	USD 1,110	26.00
2025-04-10	SELL	-384	19.300	19.800	19.750	USD -7,584	26.52 Profit of 2,600 on sale
2025-04-08	SELL	-48	18.600	20.100	19.950	USD -958	26.69 Profit of 323 on sale
2025-04-07	SELL	-48	19.090	19.965	19.878	USD -954	26.77 Profit of 331 on sale
2025-04-04	SELL	-245	18.570	18.990	18.948	USD -4,642	26.87 Profit of 1,941 on sale
2025-04-01	BUY	200	19.780	20.220	20.176	USD 4,035	27.04
2025-03-31	SELL	-147	20.020	20.300	20.272	USD -2,980	27.12 Profit of 1,007 on sale
2025-03-21	BUY	1,251	20.520	21.010	20.961	USD 26,222	27.65
2025-03-14	SELL	-736	19.290	19.550	19.524	USD -14,370	28.19 Profit of 6,375 on sale
2025-03-07	SELL	-90	20.210	20.915	20.845	USD -1,876	28.85 Profit of 720 on sale
2025-03-04	SELL	-45	22.230	22.580	22.545	USD -1,015	29.21 Profit of 300 on sale
2025-02-25	BUY	90	25.090	25.360	25.333	USD 2,280	29.67
2025-02-19	SELL	-45	27.190	27.565	27.528	USD -1,239	29.93 Profit of 108 on sale
2025-02-13	BUY	132	27.610	28.480	28.393	USD 3,748	30.14
2025-02-12	BUY	44	27.850	28.270	28.228	USD 1,242	30.19
2025-02-11	BUY	176	28.120	28.220	28.210	USD 4,965	30.23
2024-12-30	SELL	-1,533	26.660	26.790	26.777	USD -41,049	31.45 Profit of 7,156 on sale
2024-11-18	SELL	-720	27.900	28.820	28.728	USD -20,684	32.79 Profit of 2,922 on sale
2024-11-08	SELL	-48	33.290	33.870	33.812	USD -1,623	32.75 Loss of -51 on sale
2024-10-21	SELL	-49	31.870	33.300	33.157	USD -1,625	0.00 Loss of -1,625 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CSTL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	118,658	0	203,890	58.2%
2025-09-18	86,693	0	206,739	41.9%
2025-09-17	27,039	6	77,521	34.9%
2025-09-16	49,973	0	213,490	23.4%
2025-09-15	39,246	0	306,415	12.8%
2025-09-12	35,391	25	88,193	40.1%
2025-09-11	38,030	0	102,193	37.2%
2025-09-10	53,522	0	150,491	35.6%
2025-09-09	62,336	1	93,444	66.7%
2025-09-08	55,932	101	94,956	58.9%
2025-09-05	43,845	0	67,696	64.8%
2025-09-04	54,073	9,081	123,437	43.8%
2025-09-03	118,250	292	218,155	54.2%
2025-09-02	172,938	4,866	229,116	75.5%
2025-08-29	123,508	0	164,417	75.1%
2025-08-28	172,359	0	231,075	74.6%
2025-08-27	246,681	7,090	407,342	60.6%
2025-08-26	122,908	0	161,302	76.2%
2025-08-25	66,064	0	106,769	61.9%
2025-08-22	85,963	0	114,432	75.1%
2025-08-21	37,391	0	56,087	66.7%
2025-08-20	55,009	17	93,763	58.7%
2025-08-19	32,624	0	103,240	31.6%
2025-08-18	34,968	600	85,744	40.8%
2025-08-15	69,817	403	151,957	45.9%
2025-08-14	73,127	0	199,061	36.7%
2025-08-13	645,533	625	1,181,130	54.7%
2025-08-12	120,906	0	187,676	64.4%
2025-08-11	56,051	0	132,771	42.2%
2025-08-08	62,700	0	231,887	27.0%
2025-08-07	121,021	24	333,249	36.3%
2025-08-06	164,078	4	488,862	33.6%
2025-08-05	238,600	915	767,447	31.1%
2025-08-04	88,100	0	384,562	22.9%
2025-08-01	66,030	0	114,012	57.9%
2025-07-31	83,711	11	144,237	58.0%
2025-07-30	43,550	0	132,032	33.0%
2025-07-29	42,809	0	79,027	54.2%
2025-07-28	32,280	814	104,204	31.0%
2025-07-25	33,072	0	82,331	40.2%
2025-07-24	50,249	0	111,612	45.0%
2025-07-23	58,579	0	129,459	45.2%
2025-07-22	59,718	404	155,281	38.5%
2025-07-21	92,013	29	192,039	47.9%
2025-07-18	82,490	0	165,415	49.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE